SCHEMBL362294

SCHEMBL362294

CCN(CC)c1ccc2c(C)c(-c3ccc(C4=CC(=O)NC4=O)cc3)c(=O)oc2c1.FC1C=Cc2ccccc2O1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 9/20 0.51
▸ KDM4E B2RXH2 6/20 0.51
▸ L3MBTL1 Q9Y468 4/20 0.51
▸ HPGD P15428 4/20 0.51
▸ MAPT P10636 3/20 0.51
▸ HIF1A Q16665 2/20 0.51
▸ SMN1; SMN2 Q16637 1/20 0.51
▸ EP300 Q09472 1/20 0.49
▸ HTT P42858 5/20 0.42
▸ TDP1 Q9NUW8 3/20 0.42
▸ ATM Q13315 6/20 0.39
▸ GLA P06280 5/20 0.39
▸ GAA P10253 2/20 0.39
▸ KLK7 P49862 1/20 0.39
▸ CASP1 P29466 5/20 0.38
▸ CASP7 P55210 5/20 0.38
▸ HSD17B10 Q99714 5/20 0.38
▸ LMNA P02545 2/20 0.38
▸ THRB P10828 1/20 0.38
▸ IGLV6-57 P01721 7/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5590828 0.73 ALDH1A1 (0.78) ALDH1A1KDM4EL3MBTL1HPGDMAPT
SCHEMBL13869309 0.73 ALDH1A1 (0.86) ALDH1A1KDM4EL3MBTL1HPGDMAPT
SCHEMBL8132354 0.69 ALDH1A1 (1.00) ALDH1A1KDM4EL3MBTL1HPGDMAPT
SCHEMBL28721602 0.68 ALDH1A1 (0.77) ALDH1A1KDM4EL3MBTL1HPGDMAPT
SCHEMBL29569907 0.68 ALDH1A1 (0.77) ALDH1A1KDM4EL3MBTL1HPGDMAPT
SCHEMBL5705313 0.68 EP300 (0.89) ALDH1A1KDM4EL3MBTL1HPGDMAPT
SCHEMBL13869289 0.68 ALDH1A1 (0.72) ALDH1A1KDM4EL3MBTL1HPGDMAPT
SCHEMBL13869376 0.68 ALDH1A1 (0.68) ALDH1A1KDM4EL3MBTL1HPGDMAPT
SCHEMBL29249851 0.68 ALDH1A1 (0.75) ALDH1A1KDM4EL3MBTL1HPGDMAPT
SCHEMBL28720726 0.68 ALDH1A1 (0.75) ALDH1A1KDM4EL3MBTL1HPGDMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240103013-A1 PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF VIB VZW (BE) 2024-03-28 — — US disclosed
EP-4273549-A1 PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF VIB VZW (BE) 2023-11-08 — — EP disclosed
EP-3557254-B1 PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF VIB VZW (BE) 2021-12-15 — — EP disclosed
EP-3557255-B1 PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF VIB VZW (BE) 2021-11-17 — — EP disclosed
US-11162953-B2 Protein binding domains stabilizing functional conformational states of GPCRS and uses thereof VIB VZW (BE) 2021-11-02 — — US disclosed
US-11162954-B2 Protein binding domains stabilizing functional conformational states of GPCRs and uses thereof VIB VZW (BE) 2021-11-02 — — US disclosed
EP-2593792-B1 PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF VIB VZW (BE) 2019-11-13 — — EP disclosed
US-10458993-B2 Assay for assessing conformational stability of membrane protein HEPTARES THERAPEUTICS LIMITED (GB) 2019-10-29 — — US disclosed
EP-3557255-A1 PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF VIB vzw (BE) 2019-10-23 — — EP disclosed
EP-3557257-A1 PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF VIB vzw (BE) 2019-10-23 — — EP disclosed
WO-2013179062-A2 ASSAYS HEPTARES THERAPEUTICS LIMITED (GB) 2013-12-05 — — WO disclosed
US-20130183287-A1 PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF VIB VZW (BE) 2013-07-18 — — US disclosed
US-20130137856-A1 PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2013-05-30 — — US disclosed
EP-2593792-A1 PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF VIB vzw (BE) 2013-05-22 — — EP disclosed
EP-2593791-A1 PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF VIB vzw (BE) 2013-05-22 — — EP disclosed
WO-2012120315-A2 MUTANT PROTEINS AND METHODS FOR PRODUCING THEM HEPTARES THERAPEUTICS LIMITED (GB) 2012-09-13 — — WO disclosed
WO-2012098413-A1 MUTANT G-PROTEIN COUPLED RECEPTOR PROTEINS AND METHODS FOR PRODUCING THEM HEPTARES THERAPEUTICS LIMITED (GB) 2012-07-26 — — WO disclosed
US-20120165507-A1 MUTANT PROTEINS AND METHODS FOR PRODUCING THEM HEPTARES THERAPEUTICS LIMITED (GB) 2012-06-28 — — US disclosed
WO-2012007594-A1 PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF VIB VZW (BE) 2012-01-19 — — WO disclosed
WO-2012007593-A1 PROTEIN BINDING DOMAINS STABILIZING FUNCTIONAL CONFORMATIONAL STATES OF GPCRS AND USES THEREOF VIB VZW (BE) 2012-01-19 — — WO disclosed
Send feedback